Commonly used biomarkers like carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) do not possess the necessary sensitivity or specificity for effective CCA detection (Shi et al., 2013). The gene discussed is CEACAM5; the disease is cholangiocarcinoma.